Trademark: 79340032
Status Date
Tuesday, September 12, 2023
Registration Number
7159631
Registration Date
Tuesday, September 12, 2023
Filing Date
Wednesday, December 22, 2021
Published for Opposition
Tuesday, June 27, 2023
41 Educational services in the nature of academies, namely, conducting seminars, workshops, lectures, practical experimental demonstrations in the field of glycomics, biomarker discovery, disease diagnostics, proteomics, life science company development; arranging and conducting of colloquiums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics, life science company development; arranging and conducting of conferences in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of congresses in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of seminars in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of symposiums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics; arranging and conducting of in-person educational forums in the field of glycomics, biomarker discovery, disease diagnostics, proteomics
40 Custom manufacture of medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases
5 chemical preparations for pharmaceutical purposes, namely, for calibration of diagnostics tests in a form of a glycoprotein standard; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for diagnosis of oncological diseases, autoimmune diseases and neurological diseases; stem cells for medical purposes; biological tissue cultures for medical purposes; diagnostic biomarker reagents for medical purposes; medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases
35 Retail store services for pharmaceutical preparations, chemical preparations for pharmaceutical purposes, diagnostic preparations for medical purposes, chemical preparations for medical purposes, stem cells for medical purposes, biological tissue cultures for medical purposes, diagnostic biomarker reagents for medical purposes, blood testing apparatus, testing apparatus for medical purposes, diagnostic apparatus for medical purposes, medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases; online retail store services for pharmaceutical preparations, chemical preparations for pharmaceutical purposes, diagnostic preparations for medical purposes, chemical preparations for medical purposes, stem cells for medical purposes, biological tissue cultures for medical purposes, diagnostic biomarker reagents for medical purposes, blood testing apparatus, testing apparatus for medical purposes, diagnostic apparatus for medical purposes, medical test sets comprised of enzymes for medical purposes, antibodies for medical purposes, lectins being glycan-recognising proteins for medical use, glycoprotein standard for medical use, enzymatic substrates for medical purposes, blocking agents for medical use, all for the diagnosis of diseases
44 Medical services; pharmacy advice, namely, pharmaceutical advice for diagnostic and pharmaceutical companies; health counselling; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
10 Blood testing apparatus; testing apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids; diagnostic apparatus for medical purposes for testing glycans in the nature of complex carbohydrates and sugars attached to proteins and lipids
42 Chemical analysis; chemical research; biological research; scientific laboratory services; scientific research; medical and scientific research, namely, conducting clinical validations trials for diagnostic and pharmaceutical companies; medical research
Jan 8, 2024
Final Decision Transaction Processed By Ib
Dec 14, 2023
Final Disposition Notice Sent To Ib
Dec 14, 2023
Final Disposition Processed
Dec 12, 2023
Final Disposition Notice Created, To Be Sent To Ib
Sep 12, 2023
Notice Of Registration Confirmation Emailed
Sep 12, 2023
Registered-Principal Register
Jun 27, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 27, 2023
Published For Opposition
Jun 25, 2023
Notification Processed By Ib
Jun 8, 2023
Notification Of Possible Opposition Sent To Ib
Jun 7, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 23, 2023
Approved For Pub - Principal Register
Apr 24, 2023
Teas/Email Correspondence Entered
Apr 24, 2023
Correspondence Received In Law Office
Apr 24, 2023
Teas Request For Reconsideration Received
Mar 12, 2023
Notification Of Final Refusal Emailed
Mar 12, 2023
Final Refusal E-Mailed
Mar 12, 2023
Final Refusal Written
Feb 27, 2023
Teas/Email Correspondence Entered
Feb 26, 2023
Correspondence Received In Law Office
Feb 26, 2023
Teas Response To Office Action Received
Jan 13, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 13, 2023
Teas Change Of Correspondence Received
Jan 13, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 13, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 13, 2023
Teas Change Of Owner Address Received
Jan 4, 2023
Refusal Processed By Ib
Dec 10, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Dec 9, 2022
Refusal Processed By Mpu
Sep 29, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Sep 28, 2022
Non-Final Action Written
Sep 27, 2022
Assigned To Examiner
Jul 1, 2022
Change Of Name/Address Rec'd From Ib
May 17, 2022
Application Filing Receipt Mailed
May 13, 2022
New Application Office Supplied Data Entered
May 12, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
